Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 6.4B | 6.9B | 6.9B | 7.4B |
| Cost of revenue | 5.6B | 5.7B | 5.8B | 5.9B |
| Gross profit | 867M | 1.2B | 1.1B | 1.5B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 1.1B | 950M | 1.1B | 1.1B |
| Operating income | -223M | 278M | 38M | 398M |
| Non operating interest income | ||||
| Income | 84M | 105M | 121M | 130M |
| Expense | 35M | 47M | 54M | 55M |
| Other income expense | -18M | -7M | -16M | 5M |
| Pretax income | -192M | 329M | 89M | 478M |
| Tax provision | -43M | 68M | 22M | 111M |
| Net income | -149M | 261M | 67M | 367M |
| Basic EPS | -0.3 | 0.4 | 0.1 | 0.6 |
| Diluted EPS | -0.3 | 0.4 | 0.1 | 0.6 |
| Basic average shares | 654.3M | 666.6M | 671.1M | 671.1M |
| Diluted average shares | 654.3M | 718.1M | 673.3M | 720.4M |
| EBITDA | 257M | 794M | 598M | 930M |
| Net income from continuing op. | -149M | 261M | 67M | 367M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | -5M | 0 | -5M |